经腹膜后入路的新型手术机器人系统 KD-SR-01 行部分肾切除术。
Partial nephrectomy through retroperitoneal approach with a new surgical robot system, KD-SR-01.
机构信息
Department of Urology, Peking University First Hospital. Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Department of Urology, Civil Aviation General Hospital, Civil Aviation Medical College of Peking University, Beijing, China.
出版信息
Int J Med Robot. 2022 Apr;18(2):e2352. doi: 10.1002/rcs.2352. Epub 2021 Nov 20.
BACKGROUND
To present our experiences with partial nephrectomy (PN) through retroperitoneal approach (RP) with the Kangduo robotic system.
METHODS
From December 2020 to February 2021, the perioperative data of 11 patients underwent PN through RP with the Kangduo robotic system were collected prospectively.
RESULTS
For the R.E.N.A.L. nephrometry score, 72.7% of patients had a low score (4-6) and 27.3% of patients had a medium score (7-9). Seven tumours were posterior (P), four tumours were on the midline (X). All procedures were completed successfully. The median warm ischemia time was 18.5 (IQR, 13.7-21.0) min. None of the patients had positive surgical margins at definitive histology (all pT1a). No high-grade perioperative complications or device-related adverse events occurred. At a mean follow-up of 8 ± 0.8 months, no complications occurred in all patients.
CONCLUSIONS
RPPN using the novel Kangduo robotic system is a safe and effective option for managing posterior and lateral renal tumours with R.E.N.A.L. nephrometry scores ≤9.
背景
介绍我们使用康多机器人系统经腹膜后入路（RP）行部分肾切除术（PN）的经验。
方法
从 2020 年 12 月至 2021 年 2 月，前瞻性收集了 11 例行康多机器人系统辅助经 RP 行 PN 的患者的围手术期资料。
结果
对于 R.E.N.A.L. 肾脏解剖评分，72.7%的患者为低评分（4-6），27.3%的患者为中评分（7-9）。7 个肿瘤位于后位（P），4 个肿瘤位于中线（X）。所有手术均成功完成。中位热缺血时间为 18.5（IQR，13.7-21.0）min。所有患者的最终病理均未见肿瘤切缘阳性（均为 pT1a）。无高级别围手术期并发症或与器械相关的不良事件发生。在平均 8±0.8 个月的随访中，所有患者均未发生并发症。
结论
对于 R.E.N.A.L. 肾脏解剖评分≤9 的后位和侧位肾脏肿瘤，使用新型康多机器人系统行后腹腔镜 PN 是一种安全有效的选择。
Zotero 插件